Influence of Diclofenac Sodium Intracanal Medication on Postoperative Pain and Matrix Metalloproteinase-9 Modulation in Necrotic Pulp Cases: A Randomised Controlled Clinical Trial
European Endodontic Journal · 16.07.2026
DOI: 10.65717/eej.2026.25032 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift European Endodontic Journal, online erschienen am 16.07.2026. Verfasst von Mohammed Awadd Ali und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endodontics, Faculty of Dentistry, Cairo University, Cairo, Egypt. Hauptthemen laut MEDLINE: Anti-Inflammatory Agents, Non-Steroidal, Dental Pulp Necrosis, Diclofenac, Matrix Metalloproteinase 9.
Themen: Schmerzmanagement
Abstract (Originalsprache)
Objective
This study aimed to assess postoperative pain outcomes and changes in periapical matrix metal-loproteinase-9 (MMP-9) levels following the use of diclofenac sodium (DcS) and calcium hydroxide Ca(OH)2 intracanal medications.
Methods
Thirty patients with necrotic single-rooted mandibular premolars were randomly assigned to DcS or Ca(OH)2 intracanal medication groups. Standard 2-visit endodontic treatment was performed. Postoperative pain was recorded following instrumentation and obturation at 6, 12, 24, and 48 hours, and MMP-9 levels were measured after chemo-mechanical preparation and after placement of intracanal medicament for 1 week.
Results
Diclofenac sodium demonstrated a significantly lower incidence and intensity of postoperative pain following the first visit compared with Ca(OH)2, particularly at 6, 12, and 24 hours. Both agents significantly decreased inflammatory biomarker levels from post-instrumentation to pre-obturation in necrotic root canals. Despite this reduction, biomarker levels remained elevated in the DcS group relative to the Ca(OH)2 group.
Conclusion
Diclofenac sodium used as an intracanal medication significantly reduced postoperative pain compared with Ca(OH)2. Ca(OH)2 demonstrated a greater reduction in MMP-9 levels, although both agents produced a marked decline in biomarker levels from post-instrumentation to pre-obturation in necrotic root canals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endodontics, Faculty of Dentistry, Cairo University, Cairo, Egypt.
- Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Cairo University, Cairo, Egypt.
ORCID-Profile: Mohammed Awadd Ali, Olfat Gamal Shaker, Nadia Saeed Hosny, Randa El Boghdadi
Zitieren
APA
Ali, M. A., Shaker, O. G., Hosny, N. S., & El Boghdadi, R. (2026). Influence of Diclofenac Sodium Intracanal Medication on Postoperative Pain and Matrix Metalloproteinase-9 Modulation in Necrotic Pulp Cases: A Randomised Controlled Clinical Trial. European Endodontic Journal. https://doi.org/10.65717/eej.2026.25032
Vancouver
Ali MA, Shaker OG, Hosny NS, El Boghdadi R. Influence of Diclofenac Sodium Intracanal Medication on Postoperative Pain and Matrix Metalloproteinase-9 Modulation in Necrotic Pulp Cases: A Randomised Controlled Clinical Trial. European Endodontic Journal. 2026. doi:10.65717/eej.2026.25032
BibTeX
@article{Ali2026,
author = {Ali, Mohammed Awadd and Shaker, Olfat Gamal and Hosny, Nadia Saeed and El Boghdadi, Randa},
title = {Influence of Diclofenac Sodium Intracanal Medication on Postoperative Pain and Matrix Metalloproteinase-9 Modulation in Necrotic Pulp Cases: A Randomised Controlled Clinical Trial},
journal = {European Endodontic Journal},
year = {2026},
doi = {10.65717/eej.2026.25032}
}
EUVIMED